These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8778594)

  • 21. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases.
    Ujfalussy I; Koó E; Seszták M; Gergely P
    Z Rheumatol; 2003 Apr; 62(2):155-60. PubMed ID: 12721703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
    Burmester GR
    MMW Fortschr Med; 2004 Sep; 146(37):10. PubMed ID: 15887693
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
    Tamura N
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2873-9. PubMed ID: 23214096
    [No Abstract]   [Full Text] [Related]  

  • 25. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of salazosulfapyridine enteric-coated capsules in therapy of rheumatoid arthritis].
    Suzuki T; Sugawara S; Yoshizawa H; Koshino T; Tanaka K
    Ryumachi; 1988 Dec; 28(6):466-7. PubMed ID: 2907950
    [No Abstract]   [Full Text] [Related]  

  • 27. Lefunomide in combination therapy.
    Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():25-30. PubMed ID: 15170905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Megaloblastic anemia associated with salazosulfapyridine treatment for rheumatoid arthritis].
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Hara S; Akioka T; Miyoshi T; Tsuji M; Takubo T; Hanafusa T
    Rinsho Ketsueki; 2008 Dec; 49(12):1609-13. PubMed ID: 19110522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with sulphasalazine and azathioprine.
    Helliwell PS
    Br J Rheumatol; 1996 May; 35(5):493-4. PubMed ID: 8646444
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 2. Salazosulfapyridine].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2910-7. PubMed ID: 22175130
    [No Abstract]   [Full Text] [Related]  

  • 31. [Markov model of decision making for basic therapy of rheumatoid arthritis: oder of monotherapy and expenses for drug therapy].
    Goriachev DV; Erdes ShF
    Ter Arkh; 2004; 76(5):35-9. PubMed ID: 15230130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.
    Fransen J; Moens HB; Speyer I; van Riel PL
    Ann Rheum Dis; 2005 Sep; 64(9):1294-8. PubMed ID: 15829574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of rheumatoid arthritis.
    Zurier RB; DeMarco DM; Liu NY
    N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
    [No Abstract]   [Full Text] [Related]  

  • 36. [Armentarium and strategies for the treatment of rheumatoid arthritis].
    Lioté F
    Rev Prat; 2005 Dec; 55(19):2146-60. PubMed ID: 16544925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
    Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing.
    Landewé RB
    Arthritis Rheum; 2003 Jan; 48(1):1-5. PubMed ID: 12528097
    [No Abstract]   [Full Text] [Related]  

  • 39. [Basic therapy of rheumatoid arthritis. 1: Characterization and rules for administration].
    Keitel W; Keitel R
    MMW Fortschr Med; 1999 Sep; 141(36):51-2. PubMed ID: 10904602
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
    Shiroky JB
    J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.